Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis

Drug and Alcohol Dependence

Volumn 65, Issue 3, 2002, Pages 283-290

  Farré, Magí ^a,d   Mas, Anna ^a   Torrens, Marta ^b   Moreno, Víctor ^c,d   Camí, Jordi ^a,e  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Buprenorphine; Levo acetylmethadol; Methadone; Opioid use

Indexed keywords

ACETYLMETHADOL; BUPRENORPHINE; METHADONE; OPIATE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RETENTION; HUMAN; MAINTENANCE THERAPY; MEDLINE; META ANALYSIS; METHADONE TREATMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

BUPRENORPHINE; HUMANS; METHADONE; METHADYL ACETATE; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS; SUBSTANCE ABUSE DETECTION; TREATMENT OUTCOME;

EID: 0036470906     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(01)00171-5     Document Type: Article

References (54)

1. Buprénorphine et substitution
2. Deaths attributable to methadone vs buprenorphine in France
3. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification programme
4. Ineffective use of psychoactive drugs. Methadone treatment is no exception
5. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent
6. Variation in methadone treatment practices: Results from a national study
7. Meta-analysis: State-of-the science
8. A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride
9. Methadone maintenance treatment in opiate dependence: A review
10. Use of buprenorphine in the treatment of opioid addiction, II: Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal
11. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction
12. Contingency management in outpatient methadone treatment: A meta-analysis
13. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
14. Methadyl acetate vs methadone
15. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
16. Buprenorphine treatment of opioid dependence: Clinical trial of daily versus alternate-day dosing
17. A controlled trial of buprenorphine treatment for opioid dependence
18. Induction with levomethadyl acetate: Safety and efficacy
19. Buprenorphine versus methadone maintenance for opioid dependence
20. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine
21. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial
22. Methadyl acetate and methadone as maintenance treatments for heroin addicts. A Veterans Administration Cooperative Study
23. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence
24. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis
25. The effects of psychosocial services in substance abuse treatment
26. Buprenorphine pharmacokinetics: Relative bioavailability of sublingual tablet and liquid formulation
27. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong
28. Meta-analysis: Formulating, evaluating, combining and reporting
29. Methadyl acetate versus methadone: The experience of one hospital
30. Randomized trial of heroin maintenance programme for addicts who fail in conventional drug treatments
31. A 3-year progress report on the implementation of LAAM in the United States
32. Six deaths linked to concomitant use of buprenorphine and benzodiazepines
33. Meta-analyses of randomized controlled trials
34. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects
35. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse
36. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance
37. Moderate- vs high-dose methadone in the treatment of opioid dependence
38. Dose-response effects of methadone in the treatment of opioid dependence
39. Methadone dose and treatment outcome
40. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users
41. Comparison of buprenorphine and methadone in the treatment of opioid dependence
42. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index
43. Effects of government recommendations on methadone prescribing in South and East England: Comparison of 1995 and 1997 surveys
44. Buprenorphine treatment for heroin addiction
45. Methadone and quality of life (Letter)
46. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment
47. Buprenorphine-related deaths among drug addicts in France: A report on 20 fatalities
48. Acute poisoning during substitution therapy based on high-dose buprenorphine. 29 clinical cases - 20 Fatal cases
49. A multilevel model framework for meta-analysis of clinical trials with binary outcomes
50. Intravenous and oral l-alfa-aceylmethadol: Pharmacodynamics and pharmacokinetics in humans
51. Clinical pharmacology of buprenorphine: Ceiling effects at high doses
52. Methods of reporting statistical results from medical research studies
53. Role of maintenance treatment in opioid dependence